Latest / Pharmacy Podcast Network / CMS’s Intent to Return the CMR Completion Rate to the Star Ratings Program | Outcomes: Insights Beyond the Counter
Transcript
- 0:05Speaker 1: You are listening to the global network of podcasters dedicated
- 0:09Speaker 1: to the pharmacy profession.
- 0:10Speaker 2: Welcome to the Pharmacy podcast Network.
- 0:32Speaker 1: My name is Ross Brye, Senior product manager and a
- 0:35Speaker 1: residence CMR guy, focusing on medication, therapy management and payer
- 0:39Speaker 1: strategies and healthcare. I'll be your guide today as we
- 0:42Speaker 1: dive into industry trends and company initiatives shaping the MTM
- 0:46Speaker 1: and payer space. With me for the conversation today is
- 0:50Speaker 1: Outcomes Director of Payer Products, Cindy Henry. Cindy, if you
- 0:53Speaker 1: want to give yourself a brief introduction, sure.
- 0:56Speaker 3: Thanks for us, Cindy Henry here. As you heard, I'm
- 1:00Speaker 3: director of Payer Product. My background is varied, but if
- 1:05Speaker 3: centered in government sponsored healthcare. I have background in working
- 1:12Speaker 3: for a health plan as well as working on the
- 1:14Speaker 3: vendor side and also pharmacy as well, So I had
- 1:18Speaker 3: a little bit of everything and looking forward to bringing
- 1:21Speaker 3: that perspective into conversations.
- 1:23Speaker 2: The different lenses to look through for sure. Cindy.
- 1:26Speaker 1: Yeah, that's really great. Yeah, well, it's awesome to have
- 1:28Speaker 1: you here for today's podcast. You know, we're just a
- 1:32Speaker 1: couple of short weeks out from CMS and the release
- 1:36Speaker 1: of the twenty twenty seven Advanced Notice. Lots of areas
- 1:40Speaker 1: in that content to cover a lot of areas getting
- 1:44Speaker 1: airtime across social media and otherwise, of course for outcomes.
- 1:50Speaker 1: A key area of focus within that advanced Notice is
- 1:53Speaker 1: around the MTM Medication Therapy Management Program and seeing CMS
- 1:58Speaker 1: again formalized there tent to bring back the CMR completion
- 2:02Speaker 1: rate for measure year twenty twenty seven. Cindy, what were
- 2:06Speaker 1: your initial reactions as you saw that content and kind
- 2:09Speaker 1: of saw reactions elsewhere.
- 2:13Speaker 3: I would say there was a obviously brief moment of
- 2:18Speaker 3: a sigh of relief or a celebration, quickly punctuated by
- 2:22Speaker 3: sort of the reality of all of the different things
- 2:26Speaker 3: happening in the landscape where this sits in that landscape.
- 2:30Speaker 3: And then as excited as I am to see this
- 2:33Speaker 3: come back, I'm also feeling for our health plans and
- 2:38Speaker 3: you know, excited for how our network's going to respond
- 2:42Speaker 3: to the need.
- 2:44Speaker 2: Yeah, I know for me personally.
- 2:47Speaker 1: Over the last year or so, as the CMR has
- 2:52Speaker 1: been in the display page, now we've seen the industry,
- 2:56Speaker 1: you know, reevaluate their strategies for stars. And that's not
- 3:00Speaker 1: just because of CMR. That's just one little microcosm in
- 3:03Speaker 1: the larger environment of the STAR ratings program and even
- 3:06Speaker 1: the larger beyond that the full Medicare program and its entirety.
- 3:10Speaker 1: So a lot of changes that are being navigated by plans.
- 3:13Speaker 1: I know we've talked about this Cindia. Is it's it's
- 3:16Speaker 1: an area that is you know, maybe the term is
- 3:20Speaker 1: precarious right now in terms of just how to step
- 3:24Speaker 1: forward down that path. I think the biggest thing that
- 3:27Speaker 1: you know, I've heard as we've been in conversation with
- 3:29Speaker 1: plans is just the strategic planning and thinking that is
- 3:35Speaker 1: going into a lot of these moments right now. You
- 3:37Speaker 1: know how to take that next step forward, whether it
- 3:40Speaker 1: is in your STAR strategy or in your larger strategy
- 3:43Speaker 1: as a you know, plan holding a Medicare contract or contracts,
- 3:47Speaker 1: how do you make those next moves right in the
- 3:50Speaker 1: right way to continue to drive on the themes that
- 3:54Speaker 1: CMS you know, cares about today but also what we're
- 3:58Speaker 1: seeing CMS intends to care about in the future.
- 4:01Speaker 3: So maybe ross what we should do before we dive
- 4:05Speaker 3: into strategies and things like that, is maybe to a
- 4:09Speaker 3: step back and explain what the CMR measure is and
- 4:13Speaker 3: what we do here at Outcomes to help you know,
- 4:16Speaker 3: with performance and success in that area. And then maybe
- 4:20Speaker 3: just just a quick little bit about how that kind
- 4:24Speaker 3: of fits into the overall sort of plan and playbook
- 4:28Speaker 3: for Stars and heat of success.
- 4:31Speaker 2: Yeah, great, great call out, Cindy. Let's step back for.
- 4:34Speaker 1: A moment just to remind our listeners of who we
- 4:37Speaker 1: are as outcomes and as as you mentioned, you know,
- 4:40Speaker 1: what we bring to the table when it comes to
- 4:42Speaker 1: MTM programs and the larger star strategy, so outcomes that
- 4:45Speaker 1: we have many decades of experience operating and managing not
- 4:50Speaker 1: only MTM programs, but many different aspects of star ratings
- 4:54Speaker 1: programs to help with quality measure improvement. Really are you know,
- 4:58Speaker 1: value war bringing to the for front is bringing local
- 5:01Speaker 1: pharmacy into that entire mix, so bringing local relationships.
- 5:05Speaker 3: Yeah, it's kind of having a moment right a community exactly,
- 5:09Speaker 3: bridging community resources. I think we've seen this a little
- 5:12Speaker 3: bit happening around the SDH space, but now we're seeing
- 5:15Speaker 3: even more concentrated effort in this area. So piling you know,
- 5:19Speaker 3: layering that on with you know, Mark, I think is
- 5:22Speaker 3: important just to call out, But yeah.
- 5:25Speaker 2: Sorry, to keep going. No, No, you're exactly right, Cindy.
- 5:28Speaker 1: Yeah, the you know, the theme of your local pharmacist.
- 5:33Speaker 1: I know when I started that Outcomes in twenty twelve,
- 5:36Speaker 1: almost fourteen years ago. Now, you know, our tagline at
- 5:40Speaker 1: that point in time was the face to face difference,
- 5:42Speaker 1: and you know, I think that resounded in the industry
- 5:46Speaker 1: at that point for reasons, and today it resounds for
- 5:49Speaker 1: other reasons, like you're alluding to, Cindy, of kind of
- 5:52Speaker 1: this hearkening back to local relationships and the ability to
- 5:56Speaker 1: support patients where they are, you know, amongst the you know,
- 6:01Speaker 1: landscape of healthcare that has continued to expand over that
- 6:05Speaker 1: period of time, continue to become more cost burdened over time,
- 6:10Speaker 1: how do you really kind of shrink that down, not
- 6:14Speaker 1: only from a cost perspective, but just literally from the
- 6:17Speaker 1: members experience.
- 6:18Speaker 2: Bring that back to home.
- 6:20Speaker 1: So that local relationship component is really something that we
- 6:24Speaker 1: ad Outcomes see as just a huge opportunity to help
- 6:28Speaker 1: healthcare to continue to you know, to lean on those
- 6:33Speaker 1: relationships that I know myself as a personal consumer of
- 6:36Speaker 1: healthcare for myself and my family becomes so critical and
- 6:41Speaker 1: valuable when I can engage in conversation about healthcare with
- 6:47Speaker 1: with a local resource that you know can understand our circumstance,
- 6:52Speaker 1: can help us to participate in the resources in our
- 6:55Speaker 1: in our community that can really allow us to improve
- 6:59Speaker 1: our improve our all care, improve our quality of life,
- 7:01Speaker 1: all the things that I think each one of us
- 7:04Speaker 1: strives for and really helps to accomplish.
- 7:07Speaker 2: So I think that's a great point, Cindy from your
- 7:10Speaker 2: standpoint too.
- 7:10Speaker 1: And that's really what we see come out when you
- 7:13Speaker 1: see the patient stories of patients that are receiving services
- 7:17Speaker 1: across any of our programs, whether it's helping to improve
- 7:20Speaker 1: a patient's adherence, close a gap and care, receive a
- 7:23Speaker 1: comprehensive medication review, all those services benefit from a local
- 7:28Speaker 1: pharmacist being being able to engage into that conversation. So yeah,
- 7:31Speaker 1: that's to your point, Cindy. That is the table we
- 7:34Speaker 1: see set in front of us is a nationwide network
- 7:38Speaker 1: of pharmacists eager to participate in these quality management programs
- 7:43Speaker 1: for health plans and help health plans achieve the quality
- 7:46Speaker 1: strategies that they're looking to, you know, accomplish. And now
- 7:50Speaker 1: with CMS in the advanced notice reiterating their intent to
- 7:54Speaker 1: bring that CMR completion right back.
- 7:56Speaker 2: You know, I think it really adds another layer of
- 7:59Speaker 2: reality to you know, maybe over the last year a
- 8:03Speaker 2: little bit of is it coming back? Is it not
- 8:05Speaker 2: coming back?
- 8:06Speaker 1: Questioning that we've heard as we've been in conversation with
- 8:09Speaker 1: health plans, But ultimately, I don't know that we've ever
- 8:12Speaker 1: seen that questioning from CMS.
- 8:13Speaker 2: If you look back at any of.
- 8:14Speaker 1: The regulatory notices or rule making from CMS, there's really
- 8:20Speaker 1: never been a question of the measure coming back. It's
- 8:22Speaker 1: always been an intentionality of CMR completion rate is going
- 8:26Speaker 1: to be on display.
- 8:27Speaker 2: Page for two years.
- 8:28Speaker 1: It's a two year period, very hard and set when
- 8:31Speaker 1: CMS made that statement, and now we're seeing them say
- 8:35Speaker 1: that two year period is up at the end of
- 8:37Speaker 1: twenty twenty six and twenty seven measure year.
- 8:39Speaker 2: Here we go, CMR completion rate is back.
- 8:43Speaker 3: Do you say, would it be safe to say rather
- 8:47Speaker 3: that we kind of been have been hedging our bits
- 8:51Speaker 3: that it was going to follow sort of the display
- 8:54Speaker 3: page cycle that we have seen, the precedent that we've
- 8:56Speaker 3: seen with other STAR measures, Even though the communications around
- 9:02Speaker 3: you know, policy and these changes has maybe been a
- 9:06Speaker 3: little bit outside of the norm from what we can
- 9:09Speaker 3: normally expect, which causes a little bit of speculation and
- 9:12Speaker 3: a little bit of an sureness for our health plans
- 9:15Speaker 3: as they plan ahead. Can you kind of just talk
- 9:18Speaker 3: a little bit about sort of what we were planning
- 9:21Speaker 3: on and what we saw during the period of before
- 9:24Speaker 3: it went to display page and during when it went
- 9:27Speaker 3: to display page.
- 9:29Speaker 2: Yeah.
- 9:29Speaker 1: I love that question because I think it you know,
- 9:33Speaker 1: it obviously alludes to the times we find ourselves in.
- 9:37Speaker 2: Today of we know where we are as.
- 9:41Speaker 1: Of this minute, of this hour of this day, but
- 9:43Speaker 1: we might not really know what tomorrow might bring from
- 9:47Speaker 1: every aspect of rulemaking and regulatory changes. You know, each
- 9:53Speaker 1: day seems to bring a new twist that maybe we
- 9:56Speaker 1: weren't anticipating or we felt have followed a different path.
- 10:02Speaker 1: So yeah, I think recognizing the space that we're in,
- 10:07Speaker 1: I am sure had an impact on plans as they
- 10:12Speaker 1: were looking at and evaluating the intentionality of CMS to
- 10:16Speaker 1: bring back the CMR completion rate measure as outcomes. You know,
- 10:21Speaker 1: we have been really heads down in We've got a
- 10:25Speaker 1: two year period of time where this measure is on
- 10:29Speaker 1: the display page, a two year period of time to
- 10:31Speaker 1: really reinvent what an MTM program looks like of high
- 10:35Speaker 1: quality and what the components of that MTM program bring
- 10:38Speaker 1: to the table. So not just focused on the outcomes
- 10:43Speaker 1: of the CMR itself, but the broader MTM program.
- 10:46Speaker 2: And how that can continue to evolve.
- 10:48Speaker 1: But within the CMR, really identifying those areas of opportunity
- 10:53Speaker 1: for efficiency while balancing high clinical quality just being super
- 10:58Speaker 1: super important. So yeah, it's it's it's definitely multifaceted in
- 11:03Speaker 1: a lot of different ways. But I don't think it'd
- 11:05Speaker 1: be fun any other way.
- 11:08Speaker 3: So true, so true.
- 11:11Speaker 1: So you.
- 11:13Speaker 3: Are often at the forefront of a lot of these
- 11:15Speaker 3: conversations as we're meeting with our payer customers. How did
- 11:21Speaker 3: the conversations change as you know, the measure has moved
- 11:27Speaker 3: into display What shifted in payer strategy during this time?
- 11:33Speaker 3: That maybe a little bit risky now that this is
- 11:37Speaker 3: becoming more important again.
- 11:39Speaker 1: Yeah, so you know, I think the key family saw
- 11:44Speaker 1: and this is I think not to be unexpected. Was
- 11:49Speaker 1: a move to display page really resulted in MTM programs
- 11:53Speaker 1: being viewed as a compliance measure for health plans, you know,
- 11:58Speaker 1: maintain compliance of your Medicare contract by uh, you know,
- 12:04Speaker 1: continuing forward the activity of your MTM program having that
- 12:11Speaker 1: continue to be a component of your Medicare contract. But
- 12:15Speaker 1: the actual performance focus of course taking a vac seat,
- 12:20Speaker 1: you know, not at all surprising. As we alluded to,
- 12:24Speaker 1: the strategies around stars have needed to shift based on
- 12:28Speaker 1: the shifting landscape of stars measures over the last you know,
- 12:32Speaker 1: a handful of years, and so with the CMR measure
- 12:36Speaker 1: moving to display, it allowed for health lends to get
- 12:39Speaker 1: that breathing room that CMS really intended by moving the
- 12:43Speaker 1: measure onto display because of the substantive changes. So, you know,
- 12:47Speaker 1: I think we saw what we anticipated and expected from
- 12:51Speaker 1: plans of you know, kind of pulling back the driving
- 12:55Speaker 1: force that they had behind CMR completion. Uh, you know
- 12:59Speaker 1: previously in measure year twenty four in earlier and now
- 13:04Speaker 1: as we see you know, a further emphasis from CMS
- 13:08Speaker 1: on the measure returning, we're really seeing that kind of
- 13:12Speaker 1: temporary pullback with kind of getting relieved, you know, right,
- 13:19Speaker 1: We're seeing the plans re ramping up their interest in
- 13:24Speaker 1: how do they scale up into twenty twenty seven in
- 13:28Speaker 1: the right way, in a meaningful way.
- 13:31Speaker 3: It kind of you know, I think about it if
- 13:34Speaker 3: I'm looking from the thousand foot view down on all
- 13:40Speaker 3: of the pressures that I see payers facing. You know,
- 13:45Speaker 3: margins are reducing, so we're looking at, you know, our
- 13:50Speaker 3: sources of revenue which used to have some room or flexibility,
- 13:53Speaker 3: they're starting to flatten. At the same time though, and
- 13:56Speaker 3: we see this strong messaging from MS around you know,
- 14:01Speaker 3: this is about clinical outcomes, which is what stars was
- 14:06Speaker 3: supposed to always be about, what pot health has always
- 14:09Speaker 3: been about. But I think you know, through the evolution
- 14:12Speaker 3: of that, we've seen ways that you know, star ratings
- 14:15Speaker 3: are gamified. Star ratings you know, are used as kind
- 14:19Speaker 3: of like a give me as far as revenue is
- 14:22Speaker 3: concerned for our for our payers. And that's not to
- 14:25Speaker 3: say that they aren't putting in the hard work to
- 14:27Speaker 3: make sure that you know, care quality as standards are
- 14:31Speaker 3: being met and that their patients are seeing improved outcomes.
- 14:34Speaker 3: But at the end of the day, right when we
- 14:36Speaker 3: talk about bottom dollar and bottom line and what our
- 14:40Speaker 3: investments are getting, you know, for us, I think, you know,
- 14:44Speaker 3: looking at flattening of some of these you know, revenue
- 14:48Speaker 3: sources is got to be concerning and then at the
- 14:52Speaker 3: same time being asked to do more right because as
- 14:55Speaker 3: we know, and something we can kind of dive into
- 14:59Speaker 3: is the denial dominator for the CMR measure is going
- 15:02Speaker 3: to be increasing. So now you're doing more, you're deploying
- 15:06Speaker 3: a higher cost program. How do you guarantee that you
- 15:09Speaker 3: get the outcomes that you need so that you can
- 15:11Speaker 3: be successful? So I think that becomes even more critical.
- 15:15Speaker 3: And where I would be looking, you know, and there's
- 15:18Speaker 3: lots to look at right now. So I think where
- 15:20Speaker 3: it makes sense to me for CMR if I'm looking
- 15:23Speaker 3: at all of that, is really making sure that there's
- 15:26Speaker 3: good proof behind the ROI and that a program can scale.
- 15:30Speaker 3: And so I think Ross, maybe you can kind of
- 15:33Speaker 3: give us a little bit of background into the growing denominator,
- 15:37Speaker 3: what the drivers are for that and sort of what
- 15:39Speaker 3: maybe to expect, you know, and that, and then maybe
- 15:43Speaker 3: you know, we can talk a little bit about how
- 15:46Speaker 3: to strategize for that.
- 15:47Speaker 1: Yeah, that's a really you know, useful dynamic. Is you know,
- 15:53Speaker 1: the changing strategies as we've talked about already in the
- 15:57Speaker 1: MTM landscape over the last year and a half.
- 16:00Speaker 2: And then along.
- 16:02Speaker 1: With that, though the increasing denominator that we saw at
- 16:06Speaker 1: the beginning of twenty twenty five because of standardized MPTM
- 16:09Speaker 1: program identification criteria. Now, maybe the saving grace that plans
- 16:16Speaker 1: have been hoping for or counting on is the measure
- 16:22Speaker 1: coming back as an active measure, has the result of
- 16:28Speaker 1: the cut points kind of resetting and recalculating anew in
- 16:32Speaker 1: twenty twenty nine based on twenty twenty seven performance. And so,
- 16:39Speaker 1: you know, I think as we've been in conversation with plans,
- 16:43Speaker 1: a lot of our emphasis and thought leadership has been
- 16:45Speaker 1: around providing our predictions of where those cut points will
- 16:51Speaker 1: land based on the activity we've seen in these display
- 16:56Speaker 1: measure years. You know, So I think to your point,
- 17:01Speaker 1: there's of course this component of growing denominator, a potential
- 17:06Speaker 1: for growing budget, and how do you manage that budget
- 17:09Speaker 1: accordingly based on the value you see as a plan
- 17:14Speaker 1: from the services within the MPTM program, but then also
- 17:17Speaker 1: alongside of that the value of the Equality Measure performance,
- 17:21Speaker 1: and then stack that up against your peers and how
- 17:25Speaker 1: they value the MPTM program they're putting their emphasis, And
- 17:29Speaker 1: you know, ultimately, I think as we've run our predictions,
- 17:31Speaker 1: we've seen that although the re entry of the CMR
- 17:36Speaker 1: measure brings the cut points down, right, it's kind of
- 17:40Speaker 1: this release of the pressure valve that we saw building
- 17:43Speaker 1: over the last decade on this measure. Although it does
- 17:46Speaker 1: release that pressure, it is I think very eye opening
- 17:49Speaker 1: to see there are a plan still continuing to make
- 17:52Speaker 1: strong investments into the EMPTM program because of the value
- 17:55Speaker 1: that they are getting out of a robust program that
- 18:00Speaker 1: allows for their patients to better manage their medications and
- 18:03Speaker 1: health conditions through medication therapy management. And so by nature
- 18:08Speaker 1: of the Star ratings program and the CMR Completion rate measure,
- 18:13Speaker 1: you see those plans pulling the star rating cut points,
- 18:18Speaker 1: and that upward pull results in a lot of shifts
- 18:23Speaker 1: in how health plans have traditionally performed in the measure
- 18:26Speaker 1: to where they would likely perform in the measure if
- 18:29Speaker 1: they're kind of display year performance remained steady into twenty
- 18:35Speaker 1: twenty seven, right, So if you, as a health plan
- 18:38Speaker 1: said well, I don't see the value at CMR and
- 18:42Speaker 1: I'm not going to make the investments, it's a bigger
- 18:43Speaker 1: investment now at twenty twenty seven than it was in
- 18:45Speaker 1: twenty twenty four. I'm going to taper back my performance
- 18:50Speaker 1: expectations than we have historically. You know, of course, that's
- 18:53Speaker 1: your prerogative, that's your strategy. Maybe that's how you're balancing
- 18:57Speaker 1: your books within the other star measures that are a
- 18:59Speaker 1: focus in phys for years, but recognize that other health
- 19:02Speaker 1: plans may not be playing that same game. They may
- 19:05Speaker 1: be playing their MPTM program in a way that they've
- 19:08Speaker 1: developed a really high, high quality focus to their MPTM
- 19:12Speaker 1: program that's allowing them to see, you know, that total
- 19:16Speaker 1: cost of care value from their program and really support
- 19:19Speaker 1: an investment into the program that drives a much higher completion.
- 19:23Speaker 2: Rate of cmrs. Then maybe you're really focused on.
- 19:27Speaker 1: So I think that's going to be the important and
- 19:29Speaker 1: interesting part of this, Cindy, is you know, contemplating there's
- 19:33Speaker 1: a lot of different aspects to how twenty to twenty
- 19:38Speaker 1: seven will play out. As I mentioned, we've you know,
- 19:42Speaker 1: done our due diligence to predict out where we feel
- 19:46Speaker 1: like that's going to land. And we're looking forward to
- 19:48Speaker 1: supporting payers as they're strategizing in this space and really
- 19:53Speaker 1: building their own business cases within their own organizations around
- 19:57Speaker 1: you know, a robust program that can not only deliver
- 20:01Speaker 1: star rating success, but also total cost of care success
- 20:04Speaker 1: or name it whatever measuring stick you're bringing to the
- 20:07Speaker 1: MTM program. How can we help you articulate that measuring
- 20:09Speaker 1: stick accordingly so you can really you know, allow the
- 20:13Speaker 1: investment to be supported. So I think that's going to
- 20:17Speaker 1: be you know, parts of it, Cindy, is you know,
- 20:20Speaker 1: how do you how do you kind of put all
- 20:21Speaker 1: those puzzle pieces together as a health plan to really
- 20:24Speaker 1: make a picture at the end of the day that's
- 20:27Speaker 1: compelling for you and for your contract to perform.
- 20:31Speaker 2: So Ross, I.
- 20:32Speaker 3: Have two things as you were kind of talking about
- 20:36Speaker 3: that that I think would be really good to kind
- 20:41Speaker 3: of elaborate on. One is we talk about total cost
- 20:44Speaker 3: of care and the role that plays in total cost
- 20:47Speaker 3: of care, which I think is a goal and a
- 20:50Speaker 3: metric outside of stars alone. So when we talk about,
- 20:56Speaker 3: you know, how does CMR drive total cost of care
- 21:00Speaker 3: or drive you know, value based care delivery, can you
- 21:04Speaker 3: kind of talk about the factors there, you know, put
- 21:08Speaker 3: yourself in you know, an executive's position. How do CMR
- 21:14Speaker 3: control total cost of care? You know, outside of star
- 21:17Speaker 3: ratings and performance? And then I think the other thing
- 21:20Speaker 3: that you touched on that'll be really important is you
- 21:24Speaker 3: know what is like the one key thing is as
- 21:27Speaker 3: payers are looking at expanded denominators, what is the key
- 21:31Speaker 3: thing that they need to keep in mind as they're
- 21:33Speaker 3: planning ahead for you know, how are they going to
- 21:36Speaker 3: deploy these programs and scale these programs.
- 21:38Speaker 1: Yeah, I think that's a really great question, Cindy, just
- 21:41Speaker 1: from the standpoint of you know, sitting that in that
- 21:44Speaker 1: executive's chair and you know, as they look out onto
- 21:48Speaker 1: the landscape of the CMR completion rate in the coming
- 21:51Speaker 1: year as it returns to an active star measure, the
- 21:53Speaker 1: first thing that I always think about from the value
- 21:56Speaker 1: proposition of the CMR is just the multi fast the
- 22:00Speaker 1: nature of the CMR itself. You know, when you hear
- 22:03Speaker 1: one story of the value of a CMR, you've really
- 22:07Speaker 1: just heard one of those stories of the patient's experience
- 22:11Speaker 1: in that CMR. Right There is you know, potential to
- 22:15Speaker 1: improve adherence performance, there's a potential to reduce emergent care needs.
- 22:20Speaker 1: There there may just be an opportunity to strengthen a
- 22:23Speaker 1: local relationship between a pharmacist and a patient to really
- 22:26Speaker 1: understand that full and comprehensive medication regiment that the patient
- 22:31Speaker 1: is taking. And so by nature of that, it really
- 22:34Speaker 1: comes down to what are the strategic pillars of the
- 22:37Speaker 1: health plan is looking to improve and how can they
- 22:39Speaker 1: design their MTM program in a way that the CMR
- 22:42Speaker 1: can help to you know, accentuate and help to support
- 22:46Speaker 1: all of those different strategic pillars for the organization. So
- 22:50Speaker 1: I think I might turn the question right back on you,
- 22:52Speaker 1: Cindy for a minute. Given your background, I'd love to
- 22:56Speaker 1: put you into the executive role as well. What are
- 22:58Speaker 1: those first steps that you take given the news that
- 23:01Speaker 1: the CMR completion right is coming back.
- 23:04Speaker 2: I think.
- 23:06Speaker 3: The first thing to do is go back to projection modeling.
- 23:10Speaker 3: Make sure that you understand, you know, as the criteria
- 23:16Speaker 3: changes and we're expecting more members to fall into the denominator.
- 23:22Speaker 3: I do feel that you know understanding what that's going
- 23:26Speaker 3: to look like and what the scope of the scale is.
- 23:30Speaker 3: I think is one starting point, right. I think then
- 23:34Speaker 3: once you understand, you know what is what is the
- 23:37Speaker 3: need here, then you start to look at levers and
- 23:41Speaker 3: as a health plan, you look at what vendors do
- 23:43Speaker 3: I have relationships with? What campaigns am I deploying? You know,
- 23:48Speaker 3: how do I best leverage the staff I already have
- 23:51Speaker 3: and the relationships I have And obviously you know thinking
- 23:55Speaker 3: about the engagement factor, how do we keep folks engaged.
- 23:59Speaker 3: So you know, lots lots of different areas within the
- 24:03Speaker 3: health plan. Working together, I think on this is pretty important.
- 24:06Speaker 3: But understanding what that new demand is going to be
- 24:09Speaker 3: is critical for you know, for day one. Then we
- 24:13Speaker 3: start to work on how do I scale right? And
- 24:15Speaker 3: I think with what comes, you know, that's one of
- 24:19Speaker 3: the strongest areas for us is our ability to scale quickly.
- 24:23Speaker 3: And that also goes back to supporting the community pharmacies
- 24:28Speaker 3: that are part of our network as well and making
- 24:30Speaker 3: sure that we're bringing them opportunities to diversify their revenue
- 24:35Speaker 3: streams away from just dispensing.
- 24:37Speaker 2: And so that's yeah, I think that's a good point today. Yeah, yeah,
- 24:41Speaker 2: is the community pharmacies as well. And I know.
- 24:46Speaker 1: One of the very first questions that we're getting from
- 24:48Speaker 1: health plans is how are you helping those community pharmacies
- 24:51Speaker 1: to prepare for twenty seven?
- 24:54Speaker 2: Right given this news, So.
- 24:55Speaker 1: You know, briefly from that standpoint too, you know, how
- 25:00Speaker 1: are we helping those community pharmacies to prepare for twenty seven?
- 25:04Speaker 3: Well, Aros, as our CMR guru and CMR product owner,
- 25:10Speaker 3: I think you're probably the best person to kind of
- 25:13Speaker 3: talk about some of the things that we're looking at,
- 25:16Speaker 3: some of the areas that you've been researching as we
- 25:19Speaker 3: look to you're responding to this demand. So you know,
- 25:23Speaker 3: obviously I have an inside look on on a lot
- 25:26Speaker 3: of this, but I think, you know, maybe you can
- 25:28Speaker 3: kind of share some of the things that you've been
- 25:30Speaker 3: looking at and some of the direction that we're heading
- 25:32Speaker 3: for CMR.
- 25:34Speaker 2: Sure, turn it right back to me.
- 25:35Speaker 1: Yeah, you know, as you already alluded to, you know,
- 25:39Speaker 1: community pharmacy and the scalability of our nationwide network, but
- 25:44Speaker 1: also just recognizing the value of those local relationships as
- 25:48Speaker 1: they're engaging with their own patients and providing MTM services.
- 25:52Speaker 1: We know that that's really where you know, all of
- 25:55Speaker 1: these great stories really truly come from as their origin.
- 26:00Speaker 1: In terms of the value of CMR services, we also
- 26:03Speaker 1: recognize that a CMR at the end of the day,
- 26:06Speaker 1: if you look at the core definition of the service,
- 26:08Speaker 1: is something that is intended to empower patients, empower patients
- 26:13Speaker 1: to self manage their medications and health conditions. And again
- 26:18Speaker 1: I mentioned before a CMR and the value of the
- 26:20Speaker 1: CMR can be multifaceted, and that means that if you
- 26:24Speaker 1: have opportunities to sit and listen in and participate in
- 26:28Speaker 1: a comprehensive medication review. They all sound very different, and
- 26:32Speaker 1: that's because every patient is bringing their own health care
- 26:34Speaker 1: context to that conversation by.
- 26:36Speaker 2: Nature of that.
- 26:37Speaker 1: You know, as all the pharmacists listening into this podcast
- 26:41Speaker 1: will know. You know, you get near the holidays and
- 26:43Speaker 1: there's going to be conversation about the holidays. You get
- 26:46Speaker 1: near a birthday or an anniversary, there's going to be
- 26:48Speaker 1: conversations on those topics as well. So there is this
- 26:52Speaker 1: kind of core conversation that exists within a CMR regardless
- 26:57Speaker 1: of the complexity of the medication regimen that might come
- 27:00Speaker 1: into play. The you know, what the patient is bringing
- 27:05Speaker 1: to the table in terms of their knowledge of their
- 27:07Speaker 1: medication regimen. So there's that core amount of conversation and
- 27:11Speaker 1: time that's going to be happening, regardless of the profile
- 27:16Speaker 1: of the patient maybe that you're bringing into the CMR conversation.
- 27:20Speaker 1: At outcomes, we're really focused on how do we help
- 27:23Speaker 1: that core cord of the conversation continue to be such
- 27:27Speaker 1: an integral and valuable part of the CMR and then
- 27:30Speaker 1: remove the constraints the burden of additional documentation that might
- 27:37Speaker 1: be necessary surrounding that conversation. So really essentially, you know,
- 27:41Speaker 1: remove some of that documentation burden and allow the pharmacists
- 27:45Speaker 1: to really step in at another level with their clinical
- 27:49Speaker 1: knowledge and use that CMR as an opportunity to kind
- 27:52Speaker 1: of no longer be maybe required to curate data and instead,
- 27:57Speaker 1: you know, allow for opportunity to to spend time in
- 28:02Speaker 1: the clinical focus of the CMR. So that's a big
- 28:06Speaker 1: part to your point, Cindy, as we think about prepping
- 28:10Speaker 1: and helping pharmacies to really get ready for the return
- 28:15Speaker 1: of this measure is to give tools and reimagine what
- 28:21Speaker 1: our workflow looks like, what the journey of receiving a
- 28:24Speaker 1: CMR looks like, to ensure that patients can get the
- 28:29Speaker 1: best care possible and pharmacists have the most streamlined way
- 28:33Speaker 1: to do that and using the latest technologies to support
- 28:37Speaker 1: that is going to be a critical component. I mean,
- 28:41Speaker 1: you know this better than I do, Cindy, But you
- 28:43Speaker 1: look at all of the new innovation models that are
- 28:46Speaker 1: coming to the table from CMMI and just the industry
- 28:50Speaker 1: and how it's shifting with new technologies that are coming
- 28:54Speaker 1: to the forefront, and that is rightfully so allowing us
- 28:59Speaker 1: new ways is to think about care delivery. So I
- 29:02Speaker 1: think there's some exciting, Yeah, some exciting opportunities for us
- 29:05Speaker 1: to really continue to see the patient remain at the
- 29:09Speaker 1: center of that, and how do we help the pharmacy
- 29:12Speaker 1: to continue to wrap themselves around and support the patient
- 29:16Speaker 1: with those new capabilities new technologies. So it's going to
- 29:19Speaker 1: be an exciting time over twenty twenty six as we
- 29:21Speaker 1: look forward to twenty twenty seven.
- 29:23Speaker 3: Yeah, I was just thinking as you were kind of
- 29:25Speaker 3: talking through some of the ways that we're innovating and
- 29:29Speaker 3: sort of the challenges that we hear about, you know,
- 29:34Speaker 3: just thinking through so as we as we're looking for
- 29:39Speaker 3: increased efficiency in the in the CMR, I think there's
- 29:44Speaker 3: a couple things that are just realities that we can't shift.
- 29:47Speaker 3: One is that the population that is typically targeted for
- 29:51Speaker 3: a CMR are often isolated. So you know, when you
- 29:55Speaker 3: get that person on a phone who's genuinely interested, you
- 29:58Speaker 3: know that that is always going to be a reality,
- 30:01Speaker 3: and you want embrace that because you want to have
- 30:04Speaker 3: a great patient experience and to build that relationship which
- 30:10Speaker 3: can then be leveraged later for further engagement. Right right, Totally,
- 30:15Speaker 3: it's important right, Because if we're really talking about extending access,
- 30:20Speaker 3: leveraging our pharmacies, letting them practice at the top of
- 30:24Speaker 3: their license, you know, and inserting them where they really
- 30:29Speaker 3: should be, which is part of the care team. Really,
- 30:32Speaker 3: that requires a real close look at the realities of
- 30:36Speaker 3: the environment that they're working in, yes, and sort of
- 30:40Speaker 3: the hurdles that they face with doing this. And so
- 30:43Speaker 3: we hear about you know, wanting to have more predictability
- 30:48Speaker 3: around some of these services and also being able to
- 30:52Speaker 3: kind of have a better sense for how do I
- 30:56Speaker 3: appropriately staff this so that you know, I can make
- 30:58Speaker 3: sure to take advantage of.
- 31:00Speaker 2: These make the model work.
- 31:02Speaker 3: Yeah, so maybe you can talk a little bit more
- 31:05Speaker 3: in detail about some of the research that you've done
- 31:08Speaker 3: and what you've found as you've done some of that
- 31:10Speaker 3: research around, like heure, are the things that we feel
- 31:15Speaker 3: like we can solve for as we're thinking about solutionarydesign?
- 31:20Speaker 2: Yeah?
- 31:20Speaker 1: Yeah, thanks, Thanks Cndy. It's a really good question, and
- 31:23Speaker 1: I think, you know, it gets to the core of
- 31:27Speaker 1: how are we you know, in that preparation, what does
- 31:29Speaker 1: that actually look like and feel like for twenty twenty
- 31:33Speaker 1: seven And so interestingly enough, I think the themes from
- 31:38Speaker 1: from our continual research remain fairly constant and steady. So
- 31:44Speaker 1: you know, what I will share may not be groundbreaking
- 31:48Speaker 1: in nature, but it kind of reverberates in terms of
- 31:52Speaker 1: the sense that these are not they're not net new,
- 31:56Speaker 1: but they are foundational. And so you know, it's things
- 32:00Speaker 1: like to your point, predictability and helping to really understand
- 32:06Speaker 1: the work model that surrounds MTM program support at the
- 32:11Speaker 1: individual pharmacy level, at a maybe regional or district level,
- 32:16Speaker 1: at a full organization level. Right, those are all really
- 32:20Speaker 1: important components of not just a solid MTM program, but
- 32:24Speaker 1: really a solid clinical services program in totality within a
- 32:28Speaker 1: pharmacy setting. And then even within that, it's understanding the journey,
- 32:35Speaker 1: the workflow model of who does what as a part
- 32:38Speaker 1: of the CMR. So you'll see more from outcomes as
- 32:40Speaker 1: we're continuing to evolve the concepts of those roles. You know, today,
- 32:45Speaker 1: if you look at our Outcomes platform, you'll recognize it's
- 32:48Speaker 1: the same experience for all and we see that that's
- 32:50Speaker 1: a really great opportunity for us to help to better
- 32:53Speaker 1: support those individual roles as they're contributing in helping to
- 32:58Speaker 1: serve your patients. Those roles in other care settings result
- 33:03Speaker 1: in different experiences, and why not in the MTM space
- 33:08Speaker 1: as well. Right, So again these are themes that aren't
- 33:13Speaker 1: aren't groundbreaking per se, but I think the technology that
- 33:16Speaker 1: we can bring to the nationwide pharmacy network that we
- 33:21Speaker 1: have at scale is what gets me really excited to
- 33:24Speaker 1: see these capabilities really flourish and help pharmacies.
- 33:29Speaker 2: So I'm really really excited to be.
- 33:32Speaker 1: A part of, you know, some of the help we
- 33:35Speaker 1: can we can bring to the forefront of tools that
- 33:39Speaker 1: can you know, reduce some of that that workflow burden,
- 33:42Speaker 1: like you said, help pharmacists to practice at the top
- 33:45Speaker 1: of their license for example.
- 33:46Speaker 2: You know, we always say that as.
- 33:47Speaker 1: A as something we aspire to do, and I think
- 33:50Speaker 1: we're really excited in twenty twenty six to deploy new
- 33:54Speaker 1: capabilities to really to really show that in action. Well,
- 33:58Speaker 1: this has been fun to have conversation with you, Cindy.
- 34:01Speaker 1: Obviously there is plenty more that we'll be evolving over
- 34:05Speaker 1: the coming year, and we're really excited as outcomes to
- 34:08Speaker 1: bring updates as we progress forward. You know, the return
- 34:12Speaker 1: of the CMR completion rate, it's one of the most
- 34:14Speaker 1: important shifts in the star's landscape heading into measure year
- 34:17Speaker 1: twenty seven, and plans that act early rebuilding MTM capacity,
- 34:22Speaker 1: tightening workflows, aligning to predicted cutpoints, they'll be in the
- 34:26Speaker 1: best position when the twenty twenty nine Star writing cycle arrives.
- 34:30Speaker 1: So if you haven't already, jump over to Outcomes MTM
- 34:34Speaker 1: dot Com to read our blog post that contains the
- 34:37Speaker 1: cutpoint predictions that we've talked about here today. We've also
- 34:40Speaker 1: got some identification rate analysis in there, so it's definitely
- 34:44Speaker 1: an opportunity for you all to get the resources that
- 34:46Speaker 1: you need to support your preparation and those steps that
- 34:50Speaker 1: Cindy was alluding to of contemplating and doing the analysis
- 34:54Speaker 1: right now to really then identify what your strategic priorities
- 34:59Speaker 1: are for the remain and dare of twenty twenty six
- 35:01Speaker 1: as you prepare for twenty twenty seven. But for today,
- 35:04Speaker 1: thank you all for listening. We're committed to bringing you
- 35:06Speaker 1: the latest insights in healthcare innovation and strategy.
- 35:10Speaker 2: If you found this valuable, subscribes.
- 35:12Speaker 1: You don't miss our next episode.
- 35:13Speaker 2: Until then, stay curious